Crohn’s and Colitis Canada Grants $2.7M to Nine IBD Researchers

Crohn’s and Colitis Canada Grants $2.7M to Nine IBD Researchers
Crohn’s and Colitis Canada has awarded $2.7 million in grants to support nine Canadian researchers studying inflammatory bowel disease (IBD). The grants include seven Grants-in-Aid of Research, intended to advance prevention, health policy and new treatments, and two Innovations in IBD Research Grants, which fund pilot studies to test innovative, high-risk/high-reward ideas. Each year, Crohn's and Colitis Canada awards new grants to research projects it considers best align with the charity’s goal of improving treatment and care for people with Crohn's disease or ulcerative colitis. So far this year, the initiative has supported 23 projects. "Funding research is at the very core of our mission to find cures for Crohn's disease and ulcerative colitis," Mina Mawani, president and CEO of Crohn's and Colitis Canada, said in a news release announcing the new
Subscribe or to access all post and page content.

One comment

  1. vincent volpe says:

    Has Celegene continued their research for a cure of Crohn’s Disease?
    They purchased a biotech company Receptos for 7.2 Billion dollars in an effort to combat this dreaded disease. Something did not go right in the phase 3 trial of the Receptos drug Ozanimod.
    Just wondering if they will they pick up the pieces and try again?
    How can a company spend Billions of dollars on a company and not get the job done?

Leave a Comment

Your email address will not be published. Required fields are marked *